Keyphrases
Vesicular Stomatitis Virus
100%
Pancreatic Cancer
100%
Oncolytic Virotherapy
100%
Pancreatic Duct Cells
37%
Adenocarcinoma Cells
25%
Oncolytic Virus
18%
Pancreatic Ductal Adenocarcinoma
15%
Combination Treatment
12%
Paclitaxel
9%
Gemcitabine
9%
Virus Infection
6%
Phase I Clinical Trial
6%
Anticancer
6%
Chemovirotherapy
6%
Rational Therapy
6%
Cell Characteristics
6%
Oncolysis
6%
Replication-competent Virus
6%
Oncolytic Therapy
6%
Permissiveness
6%
Pre-screening
6%
FDA-approved Drugs
6%
Patient Selection
6%
Single Treatment
6%
Virus Replication
6%
Oncolytic Viral Therapy
6%
Human Pancreatic Ductal Adenocarcinoma
6%
Combined Method
6%
Overcoming Resistance
6%
Medicine and Dentistry
Vesiculovirus
100%
Oncolytic Virotherapy
100%
Pancreas Cancer
100%
Pancreas Adenocarcinoma
68%
Adenocarcinoma Cell Line
25%
Gemcitabine
18%
Paclitaxel
18%
Oncolytic Virus
18%
In Vitro
9%
Viral Replication
6%
Malignant Neoplasm
6%
Pancreatic Ductal Adenocarcinoma
6%
Viral Disease
6%
Rational Emotive Behavior Therapy
6%
Pharmacology, Toxicology and Pharmaceutical Science
Virotherapy
100%
Pancreas Cancer
100%
Vesiculovirus
100%
Pancreas Adenocarcinoma
34%
Oncolytic Virus
25%
Gemcitabine
9%
Paclitaxel
9%
Malignant Neoplasm
6%
Neoplasm
6%